Publicaciones en las que colabora con Joan Montaner Villalonga (67)

2024

  1. Sex-Stratified Genome-Wide Association Study in the Spanish Population Identifies a Novel Locus for Lacunar Stroke

    Stroke, Vol. 55, Núm. 10, pp. 2462-2471

2023

  1. Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy

    Frontiers in Aging Neuroscience, Vol. 15

  2. Intensive 90-day textile wearable Holter monitoring: an alternative to detect paroxysmal atrial fibrillation in selected patients with cryptogenic stroke

    Heart and Vessels, Vol. 38, Núm. 1, pp. 114-121

  3. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Blood-Based Biomarkers to Search for Atrial Fibrillation in High-Risk Asymptomatic Individuals and Cryptogenic Stroke Patients

    Frontiers in Cardiovascular Medicine, Vol. 9

  3. Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke

    Brain, Vol. 145, Núm. 7, pp. 2394-2406

  4. Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance

    Neurologia, Vol. 37, Núm. 2, pp. 136-150

  5. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  6. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke

    European Journal of Neurology, Vol. 28, Núm. 2, pp. 540-547

  2. Circulating AQP4 levels in patients with cerebral amyloid angiopathy-associated intracerebral hemorrhage

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-15

  3. Comparison of plasma lipoprotein composition and function in cerebral amyloid angiopathy and alzheimer’s disease

    Biomedicines, Vol. 9, Núm. 1, pp. 1-14

  4. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

    Neurology

  5. Predicting Atrial Fibrillation with High Risk of Embolization with Atrial Strain and NT-proBNP

    Translational Stroke Research, Vol. 12, Núm. 5, pp. 735-741

  6. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  7. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

2020

  1. Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain

    Scientific Reports, Vol. 10, Núm. 1

  2. Large vessel occlusion is independently associated with atrial fibrillation detection

    European Journal of Neurology, Vol. 27, Núm. 8, pp. 1618-1624

  3. The value of transcranial doppler sonography in hyperperfusion syndrome after carotid artery stenting: A nationwide prospective study

    Journal of Stroke